Documented Adverse Events in GHK-Cu Clinical Literature Published dermatology studies report injection site reactions in 815% of participants, including erythema, mild edema, and temporary discomfort lasting 13 days
Sucic et al., 2019), and in particular, BPC 157 consistently decreased elevated MDA values, while MDA itself, owing to its high cytotoxicity and inhibitory action on protective enzymes, is suggested to act as a tumor promoter and a cocarcinogenic agent (Seven et al., 1999
Protocol: KPV peptide serum morning and night on clean skin
Discuss these potential mild effects so patients know they are normal
Call (203) 348-8805 or Book a Consultation Telehealth available for Connecticut residents
The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler